Literature DB >> 10587197

Intraductal papillary mucinous tumors of the pancreas.

T Nakagohri1, T Kenmochi, O Kainuma, Y Tokoro, T Asano.   

Abstract

BACKGROUND: An increasing number of intraductal papillary mucinous tumors of the pancreas have been reported in recent years. The indolent character and favorable prognosis of this neoplasm have been described.
METHODS: Intraductal papillary mucinous tumors were classified into main duct type (n = 8) and branch type (n = 28) according to the dominant location of the tumor. This single-institute study examined the clinicopathological features and outcome after surgical resection in patients with intraductal papillary mucinous tumors.
RESULTS: The gender, age, tumor size, and prognosis were quite similar for the main duct type and branch type groups. Branch type tumors were more frequently located in the head of the pancreas than were main duct type tumors. Histological examination revealed that 88% of main duct type tumors were adenocarcinomas; however, only 46% of branch type tumors were adenocarcinomas. Five-year survival rates for the patients with all main duct type tumors (n = 8), main duct type adenocarcinoma (n = 7), all branch type tumors (n = 28), and branch duct adenocarcinoma (n = 13) were 100%, 100%, 90.6%, and 90.9%, respectively.
CONCLUSIONS: Intraductal papillary mucinous tumors had a favorable prognosis after surgical treatment. A curative pancreatectomy should be indicated for this localized malignant tumor.

Entities:  

Mesh:

Year:  1999        PMID: 10587197     DOI: 10.1016/s0002-9610(99)00192-0

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  14 in total

1.  Surgical treatment of intraductal papillary mucinous neoplasms of the pancreas: the conservative approach.

Authors:  Carlos Fernandez-del Castillo
Journal:  J Gastrointest Surg       Date:  2002 Sep-Oct       Impact factor: 3.452

Review 2.  Intraductal papillary mucinous neoplasms of the pancreas--a surgical disease.

Authors:  Jens Werner; Stefan Fritz; Markus W Büchler
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2012-03-06       Impact factor: 46.802

3.  Invasive intraductal papillary mucinous carcinomas of the pancreas: predictors of survival and the role of lymph node ratio.

Authors:  Stefano Partelli; Carlos Fernandez-Del Castillo; Claudio Bassi; William Mantovani; Sarah P Thayer; Stefano Crippa; Cristina R Ferrone; Massimo Falconi; Paolo Pederzoli; Andrew L Warshaw; Roberto Salvia
Journal:  Ann Surg       Date:  2010-03       Impact factor: 12.969

4.  Prognosis of malignant intraductal papillary mucinous tumours of the pancreas after surgical resection. Comparison with pancreatic ductal adenocarcinoma.

Authors:  F Maire; P Hammel; B Terris; F Paye; J-Y Scoazec; C Cellier; M Barthet; D O'Toole; P Rufat; C Partensky; E Cuillerier; P Lévy; J Belghiti; P Ruszniewski
Journal:  Gut       Date:  2002-11       Impact factor: 23.059

5.  Main-duct intraductal papillary mucinous neoplasms of the pancreas: clinical predictors of malignancy and long-term survival following resection.

Authors:  Roberto Salvia; Carlos Fernández-del Castillo; Claudio Bassi; Sarah P Thayer; Massimo Falconi; William Mantovani; Paolo Pederzoli; Andrew L Warshaw
Journal:  Ann Surg       Date:  2004-05       Impact factor: 12.969

Review 6.  Management of mucin-producing cystic neoplasms of the pancreas.

Authors:  Stefan Fritz; Andrew L Warshaw; Sarah P Thayer
Journal:  Oncologist       Date:  2009-02-11

7.  In vivo and in vitro propagation of intraductal papillary mucinous neoplasms.

Authors:  Hirohiko Kamiyama; Mihoko Kamiyama; Seung-Mo Hong; Collins A Karikari; Ming-Tseh Lin; Michael W Borges; Margaret Griffith; Angela Young; Alexis Norris-Kirby; Conrad Lubek; Masamichi Mizuma; Georg Feldmann; Chanjuan Shi; Hong Liang; Michael G Goggins; Anirban Maitra; Ralph H Hruban; James R Eshleman
Journal:  Lab Invest       Date:  2010-03-15       Impact factor: 5.662

Review 8.  [Differentiated therapy for intraductal papillary mucinous neoplasms].

Authors:  M N Wente; B M Schmied; J Schmidt; M W Büchler
Journal:  Chirurg       Date:  2009-01       Impact factor: 0.955

9.  Suppressive effect of sulindac on branch duct-intraductal papillary mucinous neoplasms.

Authors:  Tsuyoshi Hayashi; Hirotoshi Ishiwatari; Hideyuki Ihara; Yutaka Kawano; Koichi Takada; Koji Miyanishi; Masayoshi Kobune; Rishu Takimoto; Tomoko Sonoda; Tetsuji Takayama; Junji Kato; Yoshiro Niitsu
Journal:  J Gastroenterol       Date:  2009-06-18       Impact factor: 7.527

10.  MR imaging and MR cholangiopancreatography of multifocal intraductal papillary mucinous neoplasms of the side branches: MR pattern and its evolution.

Authors:  R Manfredi; S Mehrabi; M Motton; R Graziani; M Ferrari; R Salvia; R Pozzi Mucelli
Journal:  Radiol Med       Date:  2008-07-09       Impact factor: 3.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.